Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Aromatic Sulfonamides including a Sulfonic Acid Tail: New Membrane Impermeant Carbonic Anhydrase Inhibitors for Targeting Selectively the Cancer-Associated Isoforms
Simone Giovannuzzi, Mario D’Ambrosio, Cristina Luceri, et al.
International Journal of Molecular Sciences (2021) Vol. 23, Iss. 1, pp. 461-461
Open Access | Times Cited: 18

Showing 18 citing articles:

Targeting carbonic anhydrase IX and XII isoforms with small molecule inhibitors and monoclonal antibodies
Mateusz Kciuk, Adrianna Gielecińska, Somdutt Mujwar, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 1278-1298
Open Access | Times Cited: 74
A review on ‘sulfonamides’: their chemistry and pharmacological potentials for designing therapeutic drugs in medical science
Wardha Zafar, Sajjad Hussain Sumrra, Abrar U. Hassan, et al.
Journal of Coordination Chemistry (2023) Vol. 76, Iss. 5-6, pp. 546-580
Closed Access | Times Cited: 50
Structural modification strategies of triazoles in anticancer drug development
Qianwen Guan, Ziming Gao, Yuting Chen, et al.
European Journal of Medicinal Chemistry (2024) Vol. 275, pp. 116578-116578
Closed Access | Times Cited: 16
Novel hybrid structures based on 4-Chlorobenzenesulfonyl and 1,2,3-triazoles: Synthesis, in vitro biological activities and in silico studies
Mustafa Çeşme, Sultan Onur, Elif Aksakal, et al.
Journal of Molecular Liquids (2024) Vol. 409, pp. 125501-125501
Closed Access | Times Cited: 10
Anticancer carbonic anhydrase inhibitors: a patent and literature update 2018-2022
Sridhar Goud Nerella, Priti Singh, Mohammed Arifuddin, et al.
Expert Opinion on Therapeutic Patents (2022) Vol. 32, Iss. 8, pp. 833-847
Closed Access | Times Cited: 31
Pyrazolo[4,3-c]pyridine Sulfonamides as Carbonic Anhydrase Inhibitors: Synthesis, Biological and In Silico Studies
Andrea Angeli, В. Г. Карцев, Anthi Petrou, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 3, pp. 316-316
Open Access | Times Cited: 19
Atropo/Tropo Flexibility: A Tool for Design and Synthesis of Self-Adaptable Inhibitors of Carbonic Anhydrases and Their Antiproliferative Effect
Jekaterīna Ivanova, Alessio Nocentini, Kaspars Tārs, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 8, pp. 5703-5718
Closed Access | Times Cited: 11
Thiosemicarbazone-benzenesulfonamide Derivatives as Human Carbonic Anhydrases Inhibitors: Synthesis, Characterization, and In silico Studies
Muhammed Trawally, Kübra Demir-Yazıcı, Andrea Angeli, et al.
Anti-Cancer Agents in Medicinal Chemistry (2024) Vol. 24, Iss. 9, pp. 649-667
Closed Access | Times Cited: 4
4-(3-Alkyl/benzyl-guanidino)benzenesulfonamides as selective carbonic anhydrase VII inhibitors
Morteza Abdoli, Simone Giovannuzzi, Claudiu T. Supuran, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 1568-1576
Open Access | Times Cited: 16
Development of novel amino-benzenesulfonamide derivatives and their analogues as carbonic anhydrase inhibitors: Design, synthesis, anticancer activity assessment, and pharmacokinetic studies using UPLC-MS/MS
Khaled Elsayad, Ghada F. Elmasry, Sally Tarek Mahmoud, et al.
Bioorganic Chemistry (2025) Vol. 159, pp. 108335-108335
Closed Access
Rationally Designed Pyrazolo[1,5-a]pyrimidines as Dual Inhibitors of CA IX/XII and CDK6: A Novel Approach for NSCLC Treatment
Mahmoud S. Elkotamy, Islam A Elkelesh, Simone Giovannuzzi, et al.
European Journal of Medicinal Chemistry (2025) Vol. 293, pp. 117752-117752
Closed Access
Continued Structural Exploration of Sulfocoumarin as Selective Inhibitor of Tumor-Associated Human Carbonic Anhydrases IX and XII
Simone Giovannuzzi, Clemente Capasso, Alessio Nocentini, et al.
Molecules (2022) Vol. 27, Iss. 13, pp. 4076-4076
Open Access | Times Cited: 13
6‐Aminocoumarin oxime‐ether/sulfonamides as selective hCA IX and XII inhibitors: Synthesis, evaluation, and molecular dynamics studies
Shaik Mahammad Ghouse, K. O. P. SINHA, Alessandro Bonardi, et al.
Archiv der Pharmazie (2023) Vol. 356, Iss. 10
Closed Access | Times Cited: 6
Sulfonamides linked to sulfonate estersviahydrazone functionality: synthesis, human carbonic anhydrase inhibitory activities, and molecular modeling studies
M. İhsan Han, Miyase Gözde Gündüz, Gökçe Alçı, et al.
New Journal of Chemistry (2023) Vol. 47, Iss. 9, pp. 4267-4276
Closed Access | Times Cited: 5
LncRNA BACE1-AS promotes the progression of osteosarcoma through miR-762/SOX7 axis
Chunlei Wang, Tao Zhang, Lin Yang, et al.
Molecular Biology Reports (2022) Vol. 49, Iss. 7, pp. 5853-5862
Closed Access | Times Cited: 6
2-(N-allylsulfamoyl)-N-propylbenzamide
Ayoub El Mahmoudi, Karim Chkirate, Loubna Mokhi, et al.
Molbank (2023) Vol. 2023, Iss. 3, pp. M1678-M1678
Open Access | Times Cited: 2
New 7‐hydroxycoumarin acetamide derivatives as human carbonic anhydrase IX and XII inhibitors: Design, synthesis, biological evaluation and molecular docking studies
Sarvan Maddipatla, Bulti Bakchi, Mayura Anil Shinde, et al.
Archiv der Pharmazie (2024) Vol. 358, Iss. 1
Closed Access
Progress of Section “Biochemistry” in 2022
Claudiu T. Supuran
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5873-5873
Open Access
Page 1

Scroll to top